openPR Logo
Press release

Induced Pluripotent Stem Cells Market to Reflect Impressive Growth Rate During 2017 - 2025

02-12-2018 10:51 AM CET | Health & Medicine

Press release from: Persistence Market Research

Induced Pluripotent Stem Cells Market to Reflect Impressive

Induced pluripotent stem cells are the pluripotent stem cells that are generated through the introduction of four specific genes in the adult stem cells. These induced pluripotent stem cells offer a limitless supply of un-matured or stem cells for various therapeutic purposes. Induced pluripotent stem cells are in deep R&D phase for its applications in drug development, disease modelling, and regenerative medicine.

Since the induced pluripotent stem cells are produced directly from adult stem cells, they do not require embryos, thereby not being subject to various ethical considerations. Induced pluripotent stem cells can be synthesized in patient matching similarity, and provides unlimited access to autologous cells for the transplantation procedures, neglecting the immune response or rejection factor. Induced pluripotent stem cells are mainly produced in mouse model, and from human fibroblast cells.

Request Report for TOC @ https://www.persistencemarketresearch.com/toc/17968

The additional cells such as renal epithelial cells and human keratinocytes are also used to produce induced pluripotent stem cells. A variety of genes are expressed in induced pluripotent stem cells which include Oct-3/4, Sox family, Klf family, Myc family, Nanog, Lin28, and Glis1.

The overall growth of the induced pluripotent stem cells market is driven by increasing trends in the use of regenerative medicine in drug development coupled with the expansion of research and development of the stem cells on a global level. In addition, the diverse applications of induced pluripotent stem cells for disease modelling, drug development (patient-dependent drug efficacy), and many others are driving the growth of induced pluripotent stem cell market.

The increasing use of regenerative medicine utilizing induced pluripotent stem cells, also propels the market growth. For instance, according to the estimates of National Institutes of Health (NIH), more than 500,000 people had used regenerative medicine technology in U.S. alone. However, certain ethical issues among the population can hamper the growth of induced pluripotent stem cells market.

The complications in the generation of induced pluripotent stem cells such as low efficiency, genomic insertion, tumorigenicity, and incomplete generation of stem cells, can hinder the global market of induced pluripotent stem cells.

Induced pluripotent stem cells market is expected to show an exponential growth during the forecast period. The induced pluripotent stem cells were introduced in 2006, and various technological advancements has been witnessed in recent years.

The benefits of these stem cells create lucrative opportunities for developing patient-specific therapies. However, standardization of protocols are not yet specified, and the procedure is too inadequate for clinical applications. But in contrast to that, this technology is in its R&D phase, and various public and private organizations are investing to develop novel induced pluripotent stem cells.

Geographically, global induced pluripotent stem cells market can be segmented by region into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America is expected to hold the largest market share for induced pluripotent stem cells over the forecast period, followed by Europe owing to easy availability of highly developed technology protocols and standardizations of procedures. In addition, these regions are equipped with a large population of skilled professionals, and better infrastructure, in addition to investment in research and development and hence, drives the growth of induced pluripotent stem cells market.

Asia-Pacific region is expected to be a high growth region over the forecast period owing to the increasing R&D ventures in countries such as Japan, China, and India, and increasing regulatory policies. However, the regions such as Latin America, Middle East, and Africa shows steady growth during the forecast period owing to the presence of limited healthcare infrastructure, and lack of skilled professionals.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/17968

Some of the market participants in the global induced pluripotent stem cells are BrightPath Biotherapeutics Co., Ltd, Biotime, Inc., Evotec AG, HipSci, and Fate Therapeutics, Inc.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Induced Pluripotent Stem Cells Market to Reflect Impressive Growth Rate During 2017 - 2025 here

News-ID: 939690 • Views:

More Releases from Persistence Market Research

Crypto Asset Management Market Expected to Register USD 2.28 Billion Revenue by 2031, Driven by AI and Machine Learning | Persistence Market Research
Crypto Asset Management Market Expected to Register USD 2.28 Billion Revenue by …
The crypto asset management market is emerging as a crucial segment within the financial technology and blockchain ecosystem, providing secure, transparent, and efficient solutions for managing digital assets. Crypto asset management platforms enable institutional and retail investors to track, trade, and optimize cryptocurrency portfolios, leveraging technologies like artificial intelligence (AI) and machine learning (ML) for enhanced decision-making and transaction efficiency. The increasing adoption of cryptocurrencies, coupled with regulatory clarity in
Multi-Vendor Support Services Industry Poised for Growth at 3.2% CAGR Through 2031 | Persistence Market Research
Multi-Vendor Support Services Industry Poised for Growth at 3.2% CAGR Through 20 …
The multi-vendor support services market is emerging as a critical component in enterprise IT management, helping organizations efficiently manage complex IT environments across multiple hardware and software vendors. These services provide consolidated support, maintenance, and management for diverse IT assets, reducing operational downtime and improving cost efficiency. With the increasing adoption of hybrid and multi-cloud strategies, enterprises require expert support to navigate interoperability challenges, optimize vendor relationships, and ensure seamless
Global Neuromorphic Computing Industry Anticipated to Reach USD 20.4 Billion by 2031 | Persistence Market Research
Global Neuromorphic Computing Industry Anticipated to Reach USD 20.4 Billion by …
The neuromorphic computing market is emerging as a transformative segment within the broader artificial intelligence (AI) and computing industry. Neuromorphic computing mimics the human brain's neural architecture, enabling machines to process information more efficiently and with lower energy consumption than traditional computing systems. This technology finds applications in robotics, autonomous vehicles, healthcare diagnostics, cybersecurity, and consumer electronics, making it a versatile and high-growth area. As the demand for AI-driven automation
Anime Merchandising Market Expected to Register USD 18.16 Billion Revenue by 2032, Driven by Fan Engagement and Brand Collaborations | Persistence Market Research
Anime Merchandising Market Expected to Register USD 18.16 Billion Revenue by 203 …
The global anime merchandising market has witnessed remarkable growth in recent years, driven by the worldwide popularity of anime content and increasing fan engagement. Merchandise provides fans with tangible ways to express their fandom, ranging from toys and figurines to apparel, accessories, and lifestyle products. The proliferation of e-commerce platforms and specialized online stores has further enhanced accessibility, allowing enthusiasts from different regions to purchase exclusive, limited-edition items. Collaborations with

All 5 Releases


More Releases for Induced

Evolving Market Trends In The Opioid-Induced Constipation Treatment Industry: St …
The Opioid-Induced Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Opioid-Induced Constipation Treatment Market Size During the Forecast Period? The opioid-induced constipation treatment market, valued at $1.78 billion in 2024, is projected to increase to $1.9 billion in 2025, growing
Chemotherapy Induced Anemia Market Size | Forecast
The new report published by The Business Research Company, titled Chemotherapy-Induced Anemia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the chemotherapy-induced anemia market size has grown strongly in recent years. It will grow from $2.4 billion in
Combating Chemotherapy-Induced Anemia: Market Projections 2024
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Chemotherapy-Induced Anemia Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $3.46 billion In 2028 At
Laser-Induced Breakdown Spectroscopy Market - Transforming Elemental Analysis: L …
Newark, New Castle, USA: The "Laser-Induced Breakdown Spectroscopy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Laser-Induced Breakdown Spectroscopy Market: https://www.growthplusreports.com/report/laserinduced-breakdown-spectroscopy-market/8556 This latest report researches the industry structure,
Induced Pluripotent Stem Cell Market: Factors Influencing the Growth Rate of Ind …
Researchmoz added most up-to-date research on "Global Market Study on Induced Pluripotent Stem Cell: APEC to Present Lucrative Research Opportunities to Vendors in Future" to its huge collection of research reports. Induced Pluripotent Stem Cell Market is expected to witness a strong CAGR of 7.0% from 2018 to 2026. In 2017, the market was worth US$ 1,254.0 Mn and is expected to reach US$ 2,299.5 Mn by the end of
Opioid Induced Side Effects Treatment Market
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group. However, opioid drugs use in